TWA
ONCE

TCI Wealth Advisors’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

TCI Wealth Advisors’s Portfolio ONCE Stock Details ONCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-2
Closed – – 1770
2018
Q3 		$0 Sell
2
-4
-67% -$274 ﹤0.01% 1656
2018
Q2 		$0 Buy
+6
New +$463 ﹤0.01% 1667

Other funds holding ONCE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

TCI Wealth Advisors's ONCE Position: Q4 2018 in Review

TCI Wealth Advisors sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q4 2018, closing a stake of 2 shares.

TCI Wealth Advisors first reported a position in ONCE in Q2 2018 and held it in 2 quarters. The position peaked at $0 in Q3 2018. 157 funds tracked by Wall St. Rank hold ONCE as of Q4 2018.

  • TCI Wealth Advisors reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q4 2018 after selling out during the quarter.
  • TCI Wealth Advisors sold 2 Spark Therapeutics, Inc. Common Stock shares in Q4 2018.
  • TCI Wealth Advisors first reported a position in Spark Therapeutics, Inc. Common Stock in Q2 2018 and held it in 2 quarters.
  • TCI Wealth Advisors's Spark Therapeutics, Inc. Common Stock position peaked at $0 in Q3 2018.
  • 157 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q4 2018.

Based on TCI Wealth Advisors's 13F filing for Q4 2018, filed 17 Jan 2019.